Nobivac BB for Cats (1dose x 5)

Target species Cats. Indications for use For active immunisation of cats, of 1 month of age or older to reduce clinical signs of Bordetella bronchiseptica associated upper respiratory tract disease. Onset of immunity: Onset of immunity was established in 8 week old cats as early as 72 hours after vaccination. Duration of immunity: The duration of immunity is up to 1 year. No data on the influence of maternal antibodies on the effect of vaccination with Nobivac Bb for cats are available. From literature it is considered that this type of intranasal vaccine is able to induce an immune response without interference from maternally derived antibodies. Contraindications None known. Special warnings for each target species If any antibiotic is administered within one week after vaccination, the vaccination should be repeated after the antibiotic treatment has been completed. Special precautions for use Only healthy cats should be vaccinated. Sneezing by cats after administration does not adversely affect the efficacy of the veterinary medicinal product. Do not administer during antibiotic treatment or in conjunction with any other intranasal veterinary medicinal products. Vaccinated animals can spread the vaccine strain of Bordetella bronchiseptica for six weeks, and there may be intermittent shedding for at least one year. Although the risk of immunocompromised humans becoming infected with Bordetella bronchiseptica is extremely low, it is advised that cats, which are in close contact with immunocompromised humans are not vaccinated with this vaccine. Dogs, pigs and unvaccinated cats may react to the vaccine strain with mild and transient respiratory signs. Other animals, such as rabbits and small rodents, have not been tested. Operator warnings In case of accidental self-administration, seek medical advice immediately and show the package leaflet or the label to the physician. Appropriate disinfection procedures should be used following use of this live bacterial vaccine. Although the risk that immunocompromised humans become infected with Bordetella bronchiseptica is extremely low, such individuals should be aware that cats can shed the organism for up to 1 year after vaccination. Adverse reactions After administration, occasionally sneezing, coughing, mild and transient discharge from the eyes or nose, may occur. In cats that show more severe signs, appropriate antibiotic treatment may be indicated. Use during pregnancy or lactation Do not use in pregnant or lactating queens. Interactions No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Vat Rate: 20%